Gov’t Approves Use of HIV injectables in Uganda
Uganda’s National Drug Authority (NDA) has approved the use of lenacapavir, a twice-yearly HIV prevention (PrEP) injection manufactured by Gilead Sciences, a U.S.-based company. The approval is a game-changer for HIV prevention, especially for people at high risk of infection. It marks a significant step toward ending AIDS by 2030.
